Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Leukemia, Myeloid, Acute × bosutinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 2 Translocation, Genetic 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1 Blast Crisis 1

Interventions

Cytarabine 6 Daunorubicin 5 Azacitidine 4 venetoclax 2 ivosidenib 2 Mitoxantrone 2 Idarubicin 2 Etoposide 2 Decitabine 2 treosulfan 1 tagraxofusp 1 revumenib 1 quizartinib 1 glasdegib 1 gilteritinib 1 fludarabine 1 etoposide phosphate 1 enasidenib 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 cc-486 1 Midazolam 1 Itraconazole 1 Granulocyte Colony-Stimulating Factor 1 Gemtuzumab 1 Drug Therapy 1 Cobicistat 1 CPX-351 1 Busulfan 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡